Tabata Takahisa, Ohbuchi Toyoaki, Kitamura Takuro, Ohkubo Jun-ichi, Hashida Koichi, Hohchi Nobusuke, Wakasugi Tetsuro, Katoh Akiko, Suzuki Hideaki
Department of Otorhinolaryngology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu.
Nihon Jibiinkoka Gakkai Kaiho. 2012 Sep;115(9):836-41. doi: 10.3950/jibiinkoka.115.836.
Tonsillectomy is one of the prevailing treatments for IgA nephropathy. This retrospective study aimed to elucidate prognostic factors for the postoperative kidney function of tonsillectomized patients with IgA nephropathy. Forty consecutive patients with IgA nephropathy who underwent tonsillectomy in our department between 1999 and 2008 were enrolled. They were 21 men and 19 women with ages ranging 14-52 years with an average age of 25.5 years. The patients were classified into remission and non-remission groups based on their kidney function assessed 1 year after surgery according to the clinical guidelines for IgA nephropathy of the Japanese Society of Nephrology. Patients' profiles and preoperative physical findings/laboratory data in the remission group were then compared with those in the non-remission group. The remission and non-remission groups included 13 and 27 patients, respectively. The remission group showed a significantly shorter interval between onset to surgery (2.3 +/- 2.1 vs. 5.0 +/- 6.7 years; p = 0.032), a lower diastolic blood pressure (66 +/- 13 vs. 75 +/- 17 mmHg; p = 0.040), a higher level of serum total protein (7.6 +/- 0.5 vs. 7.0 +/- 0.7 mg/dl; p = 0.015), and a higher degree of tonsillar hypertrophy (I degrees: II degrees: III degrees = 5 : 8: 0 vs. 21 : 6 : 0; p = 0.033) in comparison with the non-remission group. Multiple logistic regression analysis also revealed that patients with a higher level of serum total protein and those with a higher degree of tonsillar hypertrophy were more likely to recover. We should carefully consider these prognostic factors when indicating tonsillectomy for the treatment of IgA nephropathy.
扁桃体切除术是IgA肾病的常见治疗方法之一。这项回顾性研究旨在阐明接受扁桃体切除术的IgA肾病患者术后肾功能的预后因素。纳入了1999年至2008年间在我科连续接受扁桃体切除术的40例IgA肾病患者。他们中男性21例,女性19例,年龄在14至52岁之间,平均年龄25.5岁。根据日本肾脏病学会IgA肾病临床指南,根据术后1年评估的肾功能将患者分为缓解组和未缓解组。然后将缓解组患者的资料以及术前体格检查/实验室数据与未缓解组进行比较。缓解组和未缓解组分别有13例和27例患者。与未缓解组相比,缓解组从发病到手术的间隔时间显著更短(2.3±2.1年 vs. 5.0±6.7年;p = 0.032),舒张压更低(66±13 mmHg vs. 75±17 mmHg;p = 0.040),血清总蛋白水平更高(7.6±0.5 mg/dl vs. 7.0±0.7 mg/dl;p = 0.015),扁桃体肥大程度更高(I度:II度:III度 = 5 : 8: 0 vs. 21 : 6 : 0;p = 0.033)。多因素logistic回归分析还显示,血清总蛋白水平较高的患者和扁桃体肥大程度较高的患者更有可能康复。在考虑对IgA肾病患者进行扁桃体切除术治疗时,我们应仔细考虑这些预后因素。